|
Editors-in-Chief
Primo N. Lara, Jr., MD
University of California Davis
Comprehensive Cancer Center
Sacramento, CA, USA
Email: kca@iospress.com
Peter Mulders, MD, PhD
Radboud UMC
Nijmegen, The Netherlands
Email: kca@iospress.com
Associate Editors
Axel Bex, MD, PhD
Netherlands Cancer Institute, Amsterdam, The Netherlands
Toni K. Choueiri, MD
Dana-Farber Cancer Institute, Boston, MA, USA
Viktor Grünwald, MD
Medical School Hannover (MHH), Hannover, Germany
Lauren C. Harshman, MD
Dana-Farber Cancer Institute, Boston, MA, USA
Eric Jonasch, MD
The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Bradley C. Leibovich, MD
Mayo Clinic, Rochester, MN, USA
Egbert Oosterwijk, PhD
Radboud UMC, Nijmegen, The Netherlands
Yoshihiko Tomita, MD, PhD
Niigata University, Niigata, Japan
Hirotsugu Uemura, MD, PhD
Kindai University Faculty of Medicine, Osaka, Japan
Javier Puente, MD, PhD
Hospital Clinico Universitario San Carlos, Madrid, Spain
Christopher G. Wood, MD
The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Social Media Editor
Axel S. Merseburger, MD, PhD
University Hospital Schleswig-Holstein, Lübeck, Germany
Associate Editors for Reviews
Stephane Oudard, MD, PhD
Hôpital Européen Georges Pompidou, Paris, France
Sumanta Pal, MD
City of Hope, Duarte, CA, USA
Editor of Clinical Trials Corner
Mamta Parikh, MD
UC Davis Comprehensive Cancer Center, Sacramento, CA, USA
|
Editorial Board
Neeraj Agarwal, MD
Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA
Hideyuki Akaza, MD
University of Tokyo, Tokyo, Japan
Georg A. Bjarnason, MD, FRCP(C)
Sunnybrook Odette Cancer Center, Toronto, ON, Canada
William P. Bro
Kidney Cancer Association, Chicago, IL, USA
James Brugarolas, MD, PhD
University of Texas Southwestern Medical Center, Dallas, TX, USA
Ronald M. Bukowski, MD
Cleveland Clinic Foundation, Cleveland, USA
Steven C. Campbell, MD, PhD
Cleveland Clinic, Cleveland, OH, USA
Marc Dall’era, MD
UC Davis Comprehensive Cancer Center, Sacramento, CA, USA
Tanya B. Dorff, MD
City of Hope, Duarte, CA, USA
Janice P. Dutcher, MD
Cancer Research Foundation, Chappaqua, NY, USA
Tim Eisen, PhD
University of Cambridge, Cambridge, United Kingdom
Bernard Escudier, MD
Institut Gustave Roussy, Villejuif, France
Robert A. Figlin, MD
Cedars-Sinai Medical Center, Los Angeles, CA, USA
Thomas (Tom) Flaig, MD
University of Colorado School of Medicine, Aurora, CO, USA
Jorge Garcia, MD
Cleveland Clinic, Cleveland, OH, USA
Dan George, MD
Duke University School of Medicine, Durham, NC, USA
Martin Gore, PhD
The Royal Marsden Hospital and Instuitute of Cancer Research, London, United Kingdom
Rudolfo De Guzman, MD
National Kidney and Transplant Institute,
Metro Manila, Philippines
John Haanen, MD, PhD
Netherlands Cancer Institute, Amsterdam, The Netherlands
Naomi Haas, MD
University of Pennsylvania, Philadelphia, PA, USA
Hans Hammers, MD, PhD
University of Texas Southwestern, Dallas, TX, USA
Michael R. Harrison, MD
Duke Cancer Institute, Durham, NC, USA
Daniel Heng, MD, MPH
Tom Baker Cancer Center, Calgary, AB, Canada
Michelle S. Hirsch, MD, PhD
Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
James J. Hsieh, MD, PhD
Washington University School of Medicine, St. Louis, MO, USA
Thomas Hutson, DO, PharmD
US Oncology/Baylor, Houston, TX, USA
Choung Soo Kim, MD, PhD
Asan Medical Center, Seoul, South Korea
Won Kim, MD
University of California San Francisco, San Francisco, CA, USA
Christian Kollmannsberger, MD
BC Cancer Agency, Vancouver, BC, Canada
James Larkin, MD, PhD
The Institute of Cancer Research, London, United Kingdom
Marston Linehan, MD
National Cancer Institute, Bethesda, MD, USA
Borje Ljungberg, MD, PhD
Umea University, Umea, Sweden
Moshe C. Ornstein, MD
Cleveland Clinic, Cleveland, OH, USA
Susanne Osanto, MD, PhD
Leiden University Medical Center, Leiden, The Netherlands
Allan J. Pantuck, MD
UCLA Institute of Urologic Oncology, Los Angeles, USA
Elizabeth Plimack, MD
Fox Chase Cancer Center, Philadelphia, PA, USA
Camillo Porta, MD
IRCCS San Matteo University Hospital Foundation, Pavia, Italy
Thomas Powles, MD
The Royal Free NHS Trust and Barts Cancer Institute, London, United Kingdom
David I. Quinn, MBBS, PhD
University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA, USA
W. Kimryn (Kim) Rathmell, MD, PhD
Vanderbilt-Ingram Cancer Center, Nashville, TN, USA
Bruce G. Redman, MD
University of Michigan, Ann Arbor, MI, USA
Brian Rini, MD
Cleveland Clinic, Cleveland, OH, USA
Paul Russo, MD
Memorial Sloan Kettering Cancer Center, New York, NY, USA
Christopher Ryan, MD
Oregon Health Science University, Portland, OR, USA
Manuela Schmidinger, MD
University of Austria, Vienna, Austria
Brian Shuch, MD
Yale School of Medicine/Smilow Cancer Center, New Haven, CT, USA
Sandy Srinivas, MD
Stanford University, Stanford, CA, USA
Ramaprasad Srinivasan, MD, PhD
National Cancer Institute, Bethesda, MD, USA
Walter Stadler, MD
University of Chicago, Chicago, IL, USA
Mark Stein, MD
Rutgers, The State University of New Jersey, New Brunswick, NJ, USA
Cora N. Sternberg, MD
San Camillo and Forlanini Hospitals, Rome, Italy
Cezary Szczylik, MD, PhD
Oncology Military Medical Institute, Warsaw, Poland
Nizar M. Tannir, MD
MD Anderson Cancer Center, Houston, TX, USA
Ilya Tsimafeyeu, MD
Kidney Cancer Research Bureau, Russian Society of Clinical Oncology, Moscow, Russia
Robert G. Uzzo, MD
Fox Chase Cancer Center, Philadelphia, PA, USA
Ulka Vaishampayan, MD
Wayne State University, Karmanos Cancer Institute, Detroit, MI, USA
Guillermo de Velasco, MD, PhD
Hospital Universitario 12 de Octubre, Madrid, Spain
Nicholas J. Vogelzang, MD
Comprehensive Cancer Centers of Nevada (CCCN), Las Vegas, NV, USA
Martin H. Voss, MD
Memorial Sloan Kettering Cancer Center, New York, NY, USA
Stenio Zequi, MD, PhD
AC Camargo Cancer Center, Sao Paulo, Brazil
|
